Thrombus – Page 6 – Communicable Diseases Research

Catastrophic Thromboembolic Syndrome During the COVID-19 Pandemic

Cardiac/Thoracic/Vascular Surgery

Published on 2021-08-032022-10-31
Journal: Cureus [Category] COVID-19,

Vaccine Induced Immune Thrombotic Thrombocytopenia Causing a Severe Form of Cerebral Venous Thrombosis With High Fatality Rate: A Case Series

Neurology

Published on 2021-07-302022-11-01
Journal: Frontiers in Neurology [Category] COVID-19,

[키워드] Adenovirus Autopsy causing cerebral Cerebral venous thrombosis ChAdOx1 ChAdOx1 nCoV-19 characteristic Clinical course Clinicians Cluster Combination Complication COVID-19 COVID-19 vaccination COVID-19 vaccine AstraZeneca Fatality rate fibrin clot FIVE form hallmark healthy hemorrhage Hemorrhagic high mortality rate induced Infarction Inflammation Intracerebral hemorrhage leukocyte manifestation membranes outcome patients presenting progression of disease resulting SARS-CoV-2 virus Sery sinus vein thrombosis syndrome Thrombocytes thrombocytopenia Thrombus treat Treatment Vaccine venous Venous thrombosis
[DOI] 10.3389/fneur.2021.721146 PMC 바로가기 [Article Type] Neurology

Case Report: Co-occurrence of Myocarditis and Thrombotic Microangiopathy Limited to the Heart in a COVID-19 Patient

Cardiovascular Medicine

Published on 2021-07-292022-10-31
Journal: Frontiers in Cardiovascular Medicine [Category] COVID-19,

Large mural thrombus in the non-aneurysmal and non-atherosclerotic ascending aorta: a case report

Case Report

Published on 2021-07-232022-10-30
Journal: Journal of Cardiothoracic Surgery [Category] Coronavirus, SARS,

A COVID-Positive 52-Year-Old Man Presented With Venous Thromboembolism and Disseminated Intravascular Coagulation Following Johnson & Johnson Vaccination: A Case-Study

Emergency Medicine

Published on 2021-07-142022-10-31
Journal: Cureus [Category] COVID-19,

[키워드] Activation acute respiratory syndrome Ad26.COV2.S vaccine administration Adverse antibodies AstraZeneca benefit Bilateral Blood Care caused CDC center Complication Computed tomography Concentration conducted consolidations Control coronavirus Coronavirus COVID-19 coronavirus disease COVID-19 COVID-19 patient CTA D-dimer D‐dimer deep vein thrombosis (DVT) Deep venous thrombosis Deterioration Disseminated intravascular coagulation Disseminated intravascular coagulation (DIC) distribution drug DVT Dyspnea effective elevated endotracheal FDA finding food growth ICU immune immune complex increase Inflammation intensive care Intervention intravascular coagulation intubation Johnson & Johnson johnson and johnson vaccine less lobar Lungs Man manifestation moderate Moderna mRNA-based vaccine Occurrence oxygen pandemic Patient Pfizer Platelet Pneumonia positive airway pressure prevention pro-thrombotic Prothrombin time Pulmonary emboli recipient recipients reported required response risk saddle pulmonary embolism SARS-CoV-2 SARS-CoV2 infection segmental artery similarity specificity Supplemental oxygen therapy the SARS-CoV-2 the vaccine Thromboembolism thrombosis thrombotic thrombotic thrombocytopenic thrombocytopenia Thrombus transferred Vaccine venous venous thromboembolism (VTE) was performed worsened
[DOI] 10.7759/cureus.16383 PMC 바로가기 [Article Type] Emergency Medicine

Case Report: Acute Intracardiac Thrombosis in Children With Coronavirus Disease 2019 (COVID-19)

Pediatrics

Published on 2021-06-252022-10-31
Journal: Frontiers in Pediatrics [Category] COVID-19,

SARS-COV-2 colonizes coronary thrombus and impairs heart microcirculation bed in asymptomatic SARS-CoV-2 positive subjects with acute myocardial infarction

Observational Study

Published on 2021-06-242022-10-04
Journal: Critical Care [Category] MERS, 임상,

[키워드] Acute myocardial infarction Analysis Asymptomatic Asymptomatic SARS-COV-2 patients cardiovascular event colonize death defined dimension Effect evaluated Evidence evidenced female greater heart failure Hospitalization impair In-hospital inhibitor Intracoronary thrombus Logistic regression male Myocardial Myocardial infarction outcome outcomes Patient patients Percutaneous coronary intervention positive predictor presenting primary endpoint Result risk factor SARS-CoV-2 SARS-COV-2 infection secondary endpoint significantly lower specimen STEMI study population subject Support survival Symptomatic patients Thrombus thrombus burden Thrombus viral load treated ventricular Viral load
[DOI] 10.1186/s13054-021-03643-0 PMC 바로가기 [Article Type] Observational Study

Thrombus in Transit on Point-of-Care Ultrasound in COVID-19 Pneumonia: A Cause of Refractory Hypoxia Requiring Systemic Thrombolysis

Cardiology

Published on 2021-06-112022-10-31
Journal: Cureus [Category] COVID-19,

[키워드] acute respiratory syndrome Anticoagulants anticoagulation Case report cause Coagulopathy coronavirus Coronavirus disease 2019 COVID-19 D-dimer levels Deep vein thrombosis demonstrated diagnosed Diagnosis event Hispanic hypoxia Infection Intervention Patient Pneumonia Point of care ultrasound point-of-care popliteal Prophylactic pulmonary disease reduction in mortality refractory reported SARS-CoV-2 severe acute respiratory syndrome coronavirus 2 Severe COVID-19 pneumonia shown systemic therapeutic therapeutic dose Thromboembolism Thrombolysis thrombosis thrombotic Thrombotic events Thrombus Ultrasound Venous Thromboembolism Venous thrombosis
[DOI] 10.7759/cureus.15599 PMC 바로가기 [Article Type] Cardiology

Pulmonary thromboembolism in conjunction with intracavitary thrombus caused by severe acute respiratory syndrome coronavirus-2 infection in a patient living with human immunodeficiency virus

Case Report

Published on 2021-06-022022-10-28
Journal: Revista da Sociedade Brasileira de Medicina Tropic [Category] COVID-19, MERS, SARS,

Acute Pulmonary Embolism in Patients with and without COVID-19

Article

Published on 2021-05-112022-10-30
Journal: Journal of Clinical Medicine [Category] COVID-19,

[키워드] acute pulmonary embolism biological marker biological profile Computed tomography Computed tomography pulmonary angiography consecutive patient COVID-19 COVID-19 patient determinant diagnosed Embolism evidenced Hospitalization Hospitalized ICU immunothrombosis Inflammation Inflammatory intensive care lung injuries mechanism Non-COVID-19 objective outcomes patients patients with COVID-19 previous study Primary outcome Prognosis proportion prothrombotic prothrombotic state proximal pulmonary pulmonary angiography reduction Registered SARS-CoV-2 severity subsegmental suggested thrombosis Thrombus transfer transferred university was collected with COVID-19
[DOI] 10.3390/jcm10102045 PMC 바로가기 [Article Type] Article